{"id":"https://openalex.org/W4362525458","doi":"https://doi.org/10.1158/2326-6066.c.6550835","title":"Data from Secreted Fas Decoys Enhance the Antitumor Activity of Engineered and Bystander T Cells in Fas Ligand\u2013Expressing Solid Tumors","display_name":"Data from Secreted Fas Decoys Enhance the Antitumor Activity of Engineered and Bystander T Cells in Fas Ligand\u2013Expressing Solid Tumors","publication_year":2023,"publication_date":"2023-04-04","ids":{"openalex":"https://openalex.org/W4362525458","doi":"https://doi.org/10.1158/2326-6066.c.6550835"},"language":"en","primary_location":{"id":"doi:10.1158/2326-6066.c.6550835","doi":"https://doi.org/10.1158/2326-6066.c.6550835","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2326-6066.c.6550835","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/2326-6066.c.6550835","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5074998134","display_name":"Pradip Bajgain","orcid":"https://orcid.org/0000-0002-4719-8451","observed_orcids":["https://orcid.org/0000-0002-4719-8451"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pradip Bajgain","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-4719-8451","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002139799","display_name":"Alejandro G. Torres Chavez","orcid":"https://orcid.org/0000-0002-7195-0965","observed_orcids":["https://orcid.org/0000-0002-7195-0965"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alejandro G. Torres Chavez","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-7195-0965","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062878995","display_name":"Kishore Balasubramanian","orcid":"https://orcid.org/0000-0002-7271-7022","observed_orcids":["https://orcid.org/0000-0002-7271-7022"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kishore Balasubramanian","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-7271-7022","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077278114","display_name":"Lindsey Fleckenstein","orcid":"https://orcid.org/0000-0002-5277-6797","observed_orcids":["https://orcid.org/0000-0002-5277-6797"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lindsey Fleckenstein","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-5277-6797","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058005688","display_name":"Premal Lulla","orcid":"https://orcid.org/0000-0002-7707-2331","observed_orcids":["https://orcid.org/0000-0002-7707-2331"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Premal Lulla","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-7707-2331","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021029688","display_name":"Helen Elisabeth Heslop","orcid":"https://orcid.org/0000-0001-7049-7698","observed_orcids":["https://orcid.org/0000-0001-7049-7698"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Helen E. Heslop","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7049-7698","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025007556","display_name":"Juan F. Vera","orcid":"https://orcid.org/0000-0002-8242-1233","observed_orcids":["https://orcid.org/0000-0002-8242-1233"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Juan Vera","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-8242-1233","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5020956671","display_name":"Ann Marie Leen","orcid":"https://orcid.org/0000-0002-4470-1760","observed_orcids":["https://orcid.org/0000-0002-4470-1760"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ann M. Leen","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-4470-1760","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.600600004196167,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.600600004196167,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.1354999989271164,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.1103999987244606,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fas-ligand","display_name":"Fas ligand","score":0.8889999985694885},{"id":"https://openalex.org/keywords/chimeric-antigen-receptor-t-cells","display_name":"chimeric antigen receptor T cells","score":0.7540000081062317},{"id":"https://openalex.org/keywords/bystander-t-cells","display_name":"bystander T cells","score":0.8199999928474426},{"id":"https://openalex.org/keywords/pancreatic-cancer","display_name":"pancreatic cancer","score":0.7250000238418579},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.8690000176429749},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.8259999752044678},{"id":"https://openalex.org/keywords/immunosuppression","display_name":"immunosuppression","score":0.5860000252723694},{"id":"https://openalex.org/keywords/t-cell-immunotherapy","display_name":"T cell therapy","score":0.6069999933242798},{"id":"https://openalex.org/keywords/xenograft-models","display_name":"xenograft models","score":0.7129999995231628}],"concepts":[{"id":"https://openalex.org/C66008609","wikidata":"https://www.wikidata.org/wiki/Q14866113","display_name":"Fas ligand","level":4,"score":0.8364812731742859},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.619088351726532},{"id":"https://openalex.org/C19106626","wikidata":"https://www.wikidata.org/wiki/Q230749","display_name":"Bystander effect","level":2,"score":0.6168999671936035},{"id":"https://openalex.org/C51785407","wikidata":"https://www.wikidata.org/wiki/Q2627568","display_name":"Effector","level":2,"score":0.610964298248291},{"id":"https://openalex.org/C2779179475","wikidata":"https://www.wikidata.org/wiki/Q3545649","display_name":"Decoy","level":3,"score":0.5861548185348511},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5752564668655396},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4974086582660675},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.4696361720561981},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.46668821573257446},{"id":"https://openalex.org/C3875195","wikidata":"https://www.wikidata.org/wiki/Q5099363","display_name":"Chimeric antigen receptor","level":4,"score":0.4480937123298645},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.4444110095500946},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.4423525333404541},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.433480441570282},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.42494603991508484},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.41873615980148315},{"id":"https://openalex.org/C123894998","wikidata":"https://www.wikidata.org/wiki/Q425158","display_name":"Fusion protein","level":4,"score":0.41037362813949585},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.38861191272735596},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3326556086540222},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3168871998786926},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.2912070155143738},{"id":"https://openalex.org/C31573885","wikidata":"https://www.wikidata.org/wiki/Q304484","display_name":"Programmed cell death","level":3,"score":0.16339290142059326},{"id":"https://openalex.org/C40767141","wikidata":"https://www.wikidata.org/wiki/Q285697","display_name":"Recombinant DNA","level":3,"score":0.08220383524894714},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.07833549380302429},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/2326-6066.c.6550835","doi":"https://doi.org/10.1158/2326-6066.c.6550835","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2326-6066.c.6550835","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/2326-6066.c.6550835","doi":"https://doi.org/10.1158/2326-6066.c.6550835","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2326-6066.c.6550835","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4296301760","https://openalex.org/W2913245587","https://openalex.org/W3082381897","https://openalex.org/W1662819364","https://openalex.org/W4239353668","https://openalex.org/W4313359623","https://openalex.org/W2082905219","https://openalex.org/W3112128554","https://openalex.org/W1980134461","https://openalex.org/W2042811848"],"abstract_inverted_index":{"Abstract":[0],"T-cell":[1],"immunotherapy":[2],"has":[3,17],"demonstrated":[4],"remarkable":[5],"clinical":[6],"outcomes":[7],"in":[8,14,37,70,143,169],"certain":[9],"hematologic":[10],"malignancies.":[11],"However,":[12],"efficacy":[13,159],"solid":[15,38,71,171],"tumors":[16,39],"been":[18],"suboptimal,":[19],"partially":[20],"due":[21],"to":[22],"the":[23,76,92,101,109,127,158],"hostile":[24],"tumor":[25],"microenvironment":[26],"composed":[27],"of":[28,48,66,78,103,112,132,146,160],"immune-inhibitory":[29],"molecules.":[30],"One":[31],"such":[32,52],"suppressive":[33],"agent":[34],"abundantly":[35],"expressed":[36],"is":[40,83],"Fas":[41,80,99,118,154],"ligand":[42],"(FasL),":[43],"which":[44,125],"can":[45,156],"trigger":[46],"apoptosis":[47],"Fas-expressing":[49],"effector":[50,104,167],"cells":[51,55,69,87,142,168],"as":[53,134,136],"T":[54,141],"and":[56,90,120,129,164],"natural":[57],"killer":[58],"(NK)":[59],"cells.":[60,105],"To":[61],"alleviate":[62],"this":[63,113],"FasL-induced":[64],"suppression":[65],"tumor-specific":[67,166],"immune":[68],"tumors,":[72],"we":[73],"describe":[74],"here":[75],"development":[77],"a":[79,117],"decoy":[81,119],"that":[82,152],"secreted":[84,153],"by":[85,115],"engineered":[86],"upon":[88],"activation":[89],"sequesters":[91],"ligand,":[93],"preventing":[94],"it":[95],"from":[96],"engaging":[97],"with":[98],"on":[100],"surface":[102],"We":[106],"further":[107],"improved":[108],"immune-stimulatory":[110],"effects":[111],"approach":[114],"creating":[116],"IL15":[121],"cytokine":[122],"fusion":[123],"protein,":[124],"enhanced":[126],"persistence":[128],"antitumor":[130],"activity":[131],"decoy-engineered":[133],"well":[135],"bystander":[137],"chimeric-antigen":[138],"receptor":[139],"(CAR)":[140],"xenograft":[144],"models":[145],"pancreatic":[147],"cancer.":[148],"Our":[149],"data":[150],"indicate":[151],"decoys":[155],"augment":[157],"both":[161],"adoptively":[162],"transferred":[163],"endogenous":[165],"FasL-expressing":[170],"tumors.":[172]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2023-04-06T00:00:00"}